Synergistic effects of 5-aminolevulinic acid based photodynamic therapy and celecoxib via oxidative stress in human cholangiocarcinoma cells

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 2173-2186

  Kim, Cy Hyun ^a,b   Chung, Chung Wook ^a   Lee, Hye Myeong ^a   Kim, Do Hyung ^a,b   Kwak, Tae Won ^a   Jeong, Young Il ^a   Kang, Dae Hwan ^a,b  

^a National Research and Development Center for Hepatobiliary Cancer   (South Korea)

^b Pusan National University Yangsan Hospital   (South Korea)

Author keywords

Aminolevulinic acid; Celecoxib; Human cholangiocarcinoma; Photodynamic therapy; Reactive oxygen species

Indexed keywords

AMINOLEVULINIC ACID; CELECOXIB; HEME OXYGENASE 1; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BILE DUCT CARCINOMA; CANCER INHIBITION; CELL DEATH; CELL PROTECTION; CELL STRESS; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; IRRADIATION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIATION DOSE;

AMINOLEVULINIC ACID; CELECOXIB; HUMAN CHOLANGIOCARCINOMA; PHOTODYNAMIC THERAPY; REACTIVE OXYGEN SPECIES;

AMINOLEVULINIC ACID; ANALYSIS OF VARIANCE; ANIMALS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; CHOLANGIOCARCINOMA; DRUG SYNERGISM; HEME OXYGENASE-1; HUMANS; MALE; MICE, INBRED BALB C; OXIDATIVE STRESS; PHOTOCHEMOTHERAPY; PYRAZOLES; REACTIVE OXYGEN SPECIES; SULFONAMIDES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS;

EID: 84879063005     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S44394     Document Type: Article

References (35)

1. Grimm S, Mvondo D, Grune T, Breusing N. The outcome of 5-ALA-mediated photodynamic treatment in melanoma cells is influenced by vitamin C and heme oxygenase-1. Biofactors. 2011;37(1):17-24.
2. Moon YH, Park JH, Kim SA, Lee JB, Ahn SG, Yoon JH. Anticancer effect of photodynamic therapy with hexenyl ester of 5-aminolevulinic acid in oral squamous cell carcinoma. Head Neck. 2010;32(9):1136-1142.
3. Malik Z, Kostenich G, Roitman L, Ehrenberg B, Orenstein A. Topical application of 5-aminolevulinic acid, DMSO and EDTA: protoporphyrin IX accumulation in skin and tumours of mice. J Photochem Photobiol B. 1995;28(3):213-218.
4. Peng Q, Berg K, Moan J, Kongshaug M, Nesland JM. 5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research. Photochem Photobiol. 1997;65(2):235-251.
5. Peng Q, Warloe T, Berg K, et al. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer. 1997;79(12):2282-2308.
6. De Rosa FS, Marchetti JM, Thomazini JA, Tedesco AC, Bentley MV. A vehicle for photodynamic therapy of skin cancer: influence of dimethylsulphoxide on 5-aminolevulinic acid in vitro cutaneous permeation and in vivo protoporphyrin IX accumulation determined by confocal microscopy. J Control Release. 2000;65(3):359-366.
7. Peng Q, Warloe T, Moan J, et al. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts. Cancer Res. 2001;61(15):5824-5832.
8. Alvarez MG, Lacelli MS, Rivarola V, Batlle A, Fukuda H. 5-aminolevulinic acid-mediated photodynamic therapy on Hep-2 and MCF-7c3 cells. J Environ Pathol Toxicol Oncol. 2007;26(2):75-82.
9. Pierre MB, Tedesco AC, Marchetti JM, Bentley MV. Stratum corneum lipids liposomes for the topical delivery of 5-aminolevulinic acid in photodynamic therapy of skin cancer: preparation and in vitro permeation study. BMC Dermatol. 2001;1:5.
10. Frank J, Lornejad-Schafer MR, Schoffl H, Flaccus A, Lambert C, Biesalski HK. Inhibition of heme oxygenase-1 increases responsiveness of melanoma cells to ALA-based photodynamic therapy. Int J Oncol. 2007;31(6):1539-1545.
11. Sharma S, Jajoo A, Dube A. 5-Aminolevulinic acid-induced protoporphyrin-IX accumulation and associated phototoxicity in macrophages and oral cancer cell lines. J Photochem Photobiol B. 2007;88(2-3):156-162.
12. Chen R, Huang Z, Chen G, et al. Kinetics and subcellular localization of 5-ALA-induced PpIX in DHL cells via two-photon excitation fluorescence microscopy. Int J Oncol. 2008;32(4):861-867.
13. Donnelly RF, McCarron PA, Woolfson AD. Derivatives of 5-aminolevulinic Acid for photodynamic therapy. Perspect Medicin Chem. 2008;1:49-63.
14. Fotinos N, Mikulic J, Convert M, et al. 5-ALA derivative-mediated photoinactivation of Propionibacterium acnes. J Dermatol Sci. 2009; 56(3):214-216.
15. Chung CW, Kim CH, Choi KH, et al. Effect of surfactant on 5-aminolevulinic acid uptake and PpIX generation in human cholangiocarcinoma cell. Eur J Pharm Biopharm. 2012;80(2):453-458.
16. Yang SJ, Shieh MJ, Lin FH, et al. Colorectal cancer cell detection by 5-aminolaevulinic acid-loaded chitosan nano-particles. Cancer Lett. 2009;273(2):210-220.
17. Battah S, Balaratnam S, Casas A, et al. Macromolecular delivery of 5-aminolaevulinic acid for photodynamic therapy using dendrimer conjugates. Mol Cancer Ther. 2007;6(3):876-885.
18. Dognitz N, Salomon D, Zellweger M, et al. Comparison of ALA- and ALA hexyl-ester-induced PpIX depth distribution in human skin carcinoma. J Photochem Photobiol B. 2008;93(3):140-148.
19. Kim CH, Chung CW, Choi KH, et al. Effect of 5-aminolevulinic acid-based photodynamic therapy via reactive oxygen species in human cholangiocarcinoma cells. Int J Nanomedicine. 2011;6:1357-1363.
20. Wu T, Leng J, Han C, Demetris AJ. The cyclooxygenase-2 inhibitor celecoxib blocks phosphorylation of Akt and induces apoptosis in human cholangiocarcinoma cells. Mol Cancer Ther. 2004;3(3): 299-307.
21. Hsu AL, Ching TT, Wang DS, Song X, Rangnekar VM, Chen CS. The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2. J Biol hem.2000;275(15):11397-11403.
22. Ohgari Y, Miyata Y, Miyagi T, et al. Roles of porphyrin and iron metabolisms in the delta-aminolevulinic acid (ALA)-induced accumulation of protoporphyrin and photodamage of tumor cells. Photochem Photobiol. 2011;87(5):1138-1145.
23. Miyagiwa M, Ichida T, Tokiwa T, Sato J, Sasaki H. A new human cholangiocellular carcinoma cell line (HuCC-T1) producing carbohydrate antigen 19/9 in serum-free medium. In Vitro Cell Dev Biol. 1989;25(6):503-510.
24. Heo HY, Park JM, Kim CH, Han BS, Kim KS, Seol W. LRRK2 enhances oxidative stress-induced neurotoxicity via its kinase activity. Exp Cell Res. 2010;316(4):649-656.
25. Pederson LC, Buchsbaum DJ, Vickers SM, et al. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo. Cancer Res. 1997;57(19):4325-4332.
26. Watanabe Y, Asano R, Arai K, et al. In vitro and in vivo antitumor effects of recombinant bispecific antibodies based on humanized anti-EGFR antibody. Oncol Rep. 2011;26(4):949-955.
27. Plengsuriyakarn T, Viyanant V, Eursitthichai V, et al. Anticancer activities against cholangiocarcinoma, toxicity and pharmacological activities of Thai medicinal plants in animal models. BMC Complement Altern Med. 2012;12:23.
28. Lv Y, Fang M, Zheng J, et al. Low-intensity ultrasound combined with 5-aminolevulinic acid administration in the treatment of human tongue squamous carcinoma. Cell Physiol Biochem. 2012;30(2):321-333.
29. Sugiyama H, Onuki K, Ishige K, et al. Potent in vitro and in vivo antitumor activity of sorafenib against human intrahepatic cholangiocarcinoma cells. J Gastroenterol. 2011;46(6):779-789.
30. Kim JH, Lee JH, Kim KS, et al. Intratumoral delivery of paclitaxel using a thermosensitive hydrogel in human tumor xenografts. Arch Pharm Res. 2013;36(1):94-101.
31. Calin MA, Gruia M, Herascu N, Coman T. The monitoring of the accumulation of protoporphyrin IX in Walker tumours by subcutaneous administration of delta-aminolevulinic acid. J Exp Ther Oncol. 2004;4(3):247-251.
32. Yun BR, Lee MJ, Kim JH, Kim IH, Yu GR, Kim DG. Enhancement of parthenolide-induced apoptosis by a PKC-alpha inhibition through heme oxygenase-1 blockage in cholangiocarcinoma cells. Exp Mol Med. 2010;42(11):787-797.
33. Chiou YS, Tsai ML, Nagabhushanam K, et al. Pterostilbene is more potent than resveratrol in preventing azoxymethane (AOM)-induced colon tumorigenesis via activation of the NF-E2-related factor 2 (Nrf2)-mediated antioxidant signaling pathway. J Agric Food Chem. 2011;59(6):2725-2733.
34. Yoon JH, Yoon HE, Kim O, Kim SK, Ahn SG, Kang KW. The enhanced anti-cancer effect of hexenyl ester of 5-aminolaevulinic acid photodynamic therapy in adriamycin-resistant compared to non-resistant breast cancer cells. Lasers Surg Med. 2012;44(1):76-86.
35. Okimura Y, Fujita H, Ogino T, et al. Regulation of 5-aminolevulinic acid-dependent protoporphyrin IX accumulations in human histiocytic lymphoma U937 cells. Physiol Chem Phys Med NMR. 2007;39(1):69-82.